GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Marvel Biosciences MRVL.V · CAD

N/A · TSX Venture · 🇨🇦 Canada

Compare

0.12

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Marvel Biosciences — daily TSXV:MRVL Delayed
Market value
C$7.0m
Last close × shares
Volume
79.6k
Shares, 9 Nov 2026

About Marvel Biosciences

Its shares trade on TSX Venture under the ticker MRVL.V. It has been listed since 28 February 2019.

Marvel Biosciences Corp. Is a biotechnology company that utilizes a drug redevelopment approach to drug development. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-02-28. The firm develops new synthetic chemical derivatives of the original approved drug for the new disease indication. The company has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The firm's lead compound, MB-204, is a novel fluorinated derivative of Istradefylline. The firm is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.

Figures and description from our data supplier, not checked against the company's own report.

More about Marvel Biosciences →

Latest on Marvel Biosciences

Our reporting

We have not reported on Marvel Biosciences yet.

Next results

26 Nov 2026

Due on 26 Nov 2026.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Marvel Biosciences's ticker?

Marvel Biosciences trades as MRVL.V on TSX Venture, under ISIN CA57384M1077.

What was Marvel Biosciences's last closing price?

0.12 on 9 Nov 2026. The figure is in CAD and is never converted.

When does Marvel Biosciences next report results?

Results are expected on 26 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.